171596-29-5 Tadalaf...

171596-29-5 Tadalafil Tadalafil Intermediates for sale
171596-29-5 Tadalafil Tadalafil Intermediates for sale
171596-29-5 Tadalafil Tadalafil Intermediates for sale
171596-29-5 Tadalafil Tadalafil Intermediates for sale
171596-29-5 Tadalafil Tadalafil Intermediates for sale

171596-29-5 Tadalafil Tadalafil Intermediates for sale

Min.Order / FOB Price:Get Latest Price

1 Kilogram

FOB Price: USD 380.0000

  • Min.Order :1 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

171596-29-5 Tadalafil Tadalafil Intermediates for sale 171596-29-5

Quick Details

  • Appearance:white powder
  • Application:Medicine,Health Food,Agriculture,Cosmetic Industry
  • PackAge:25kg/drum
  • ProductionCapacity:100|Kilogram|Month
  • Storage:room temp
  • Transportation:by Sea,by land, by air

Superiority:

171596-29-5 Tadalafil Tadalafil Intermediates for sale 

We promise our customer following items:

1.Support product customization:

We can provide OEM&ODM , Because we have a professional design team


2.Reasonable price:
We provide high quality products with competitive price in china,

3.Low moq:
No worry about the low moq, our moq is 1 gram or lower.

3.Good and efficient service,Fast Delivery
Fast respond save client's time, we promise to reply inquiry in 24 hours including holidays and send quotation sheet and other documents in 48 hours.

4.Super-good quality
We have strict quality control system .Good reputation in Market , And have the Third party test report is available


Pls contact us

If you have any further questions or need a sample,Please do not hesitate to contact us.

Xi'an Julong Bio-Tech Co., Ltd.

 

Details:

The molecular formula of Tadafi (Tadalafil) is C22H19N3O4 with a molecular weight of 389.4, and has been widely used since 2003 to treat erectile dysfunction in men, and is known as Cialis. In 2008, Lilly sold the commercial expansion rights to PAH treatment to United Therapeutics. In June 2009, the FDA approved Tadana non-use in the United States for the treatment of pulmonary hypertension (PAH) patients, the trade name Addirca. The drug heddanafi, which treats ED, was introduced in 2003 and works 30min after administration, but its best effect is 2h after administration, which lasts 36h and is not affected by food. The dose of tadanafinal is 10 or 20 mg, the recommended initial dose is 10 mg, and the dose adjustment is based on the patient's reaction and adverse reactions. Pre-market studies showed that after 12 weeks of oral 10 or 20mg of tanafina, the efficiency was 67% and 81%, respectively. Many studies have shown that dana non-therapeutic ED has better efficacy.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View